Chuanmin Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chuanmin Tao has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Zhonghao Wang
Department of Laboratory Medicine West China Hospital Sichuan University Chengdu China
9 shared publicationsZhuoyun Tang
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China
9 shared publicationsYanhua Zhao
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China
7 shared publications- Dongdong Li
Department of Laboratory Medicine, West China Hospital of Sichuan University
5 shared publications Shu Feng
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
5 shared publicationsYinhao Wei
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China
5 shared publications
Latest Publications
- 5 November 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- p. 1-15
Triglyceride-dependent discordance in routine LDL cholesterol reporting during postprandial lipaemia: a self-controlled repeated-measures study
Low-density lipoprotein cholesterol (LDL-C) is a well-established causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and remains the primary treatment target in major lipid-manag...
- 5 November 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- p. 1-15
Triglyceride-dependent discordance in routine LDL cholesterol reporting during postprandial lipaemia: a self-controlled repeated-measures study
Low-density lipoprotein cholesterol (LDL-C) is a well-established causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and remains the primary treatment target in major lipid-manag...
- 10 October 2026
- Published by Springer Nature in Endocrine
- Vol. 91 (1) , 342
Dynamic transitions from prediabetes to diabetes and incident cardiovascular events in middle-aged and older chinese adults: a nationwide longitudinal study
- 10 October 2026
- Published by Springer Nature in Endocrine
- Vol. 91 (1) , 342
Dynamic transitions from prediabetes to diabetes and incident cardiovascular events in middle-aged and older chinese adults: a nationwide longitudinal study
- Open Access
Increased Coinfection of Mycoplasma pneumoniae and Chlamydia pneumoniae Among COVID‐19‐Positive Kidney Transplant Recipients
Background: Kidney transplant recipients (KTRs) are highly susceptible to infections due to chronic immunosuppression. During the COVID‐19 pandemic, their risk of atypical bacterial coinfections may have changed, but this impact remains unclear. This study aimed to assess Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) coinfection patterns in COVID‐19‐positive KTRs. Methods: We retrospectively analyzed hospitalized patients between December 2017 and January 2025 to assess winter‐month positivity rates of MP and CP. Department‐level associations with COVID‐19 status were examined, and a focused analysis of 228 KTRs compared demographic, clinical, and laboratory data between COVID‐19‐positive and ‐negative groups. Results: MP and CP‐positive detection rates declined during 2020–2021 but rebounded sharply in the winter of 2022, while other respiratory viruses showed no similar increases. An increased risk of coinfection was particularly associated with the Nephrology, Respiratory, and Emergency Departments, where COVID‐19‐positive patients had significantly higher MP/CP positivity rates. Within the Nephrology Department, KTRs represented the most vulnerable subgroup. Compared with COVID‐19‐negative KTRs, COVID‐19‐positive KTRs showed significantly higher rates of pneumonia on imaging (96.3% vs. 80.9%, p = 0.001), MP infection (37.0% vs. 11.6%, p < 0.001), and CP infection (29.6% vs. 8.8%, p < 0.001). Laboratory test results revealed marked immune impairments in COVID‐19‐positive KTRs, including lower leukocyte, lymphocyte, and monocyte counts, profound depletion of T lymphocyte subsets (CD3 + CD4 + , CD3 + CD8 + ), and reduced natural killer cell counts, while hepatic and renal function indices remained largely comparable. Conclusions: The winter rebound of MP and CP infections during the epidemic wave of the severe acute respiratory syndrome coronavirus 2 Omicron variant appeared most pronounced among KTRs, especially those with concurrent COVID‐19 infection. The elevated coinfection risk may be explained by combined impairments of adaptive and innate immunity rather than organ dysfunction. These findings underscore the need for heightened surveillance, early diagnostic testing, and tailored preventive strategies for transplant recipients and other high‐risk populations during and after COVID‐19 surges.
Open AccessIncreased Coinfection of Mycoplasma pneumoniae and Chlamydia pneumoniae Among COVID‐19‐Positive Kidney Transplant Recipients
Background: Kidney transplant recipients (KTRs) are highly susceptible to infections due to chronic immunosuppression. During the COVID‐19 pandemic, their risk of atypical bacterial coinfections may have changed, but this impact remains unclear. This study aimed to assess Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) coinfection patterns in COVID‐19‐positive KTRs. Methods: We retrospectively analyzed hospitalized patients between December 2017 and January 2025 to assess winter‐month positivity rates of MP and CP. Department‐level associations with COVID‐19 status were examined, and a focused analysis of 228 KTRs compared demographic, clinical, and laboratory data between COVID‐19‐positive and ‐negative groups. Results: MP and CP‐positive detection rates declined during 2020–2021 but rebounded sharply in the winter of 2022, while other respiratory viruses showed no similar increases. An increased risk of coinfection was particularly associated with the Nephrology, Respiratory, and Emergency Departments, where COVID‐19‐positive patients had significantly higher MP/CP positivity rates. Within the Nephrology Department, KTRs represented the most vulnerable subgroup. Compared with COVID‐19‐negative KTRs, COVID‐19‐positive KTRs showed significantly higher rates of pneumonia on imaging (96.3% vs. 80.9%, p = 0.001), MP infection (37.0% vs. 11.6%, p < 0.001), and CP infection (29.6% vs. 8.8%, p < 0.001). Laboratory test results revealed marked immune impairments in COVID‐19‐positive KTRs, including lower leukocyte, lymphocyte, and monocyte counts, profound depletion of T lymphocyte subsets (CD3 + CD4 + , CD3 + CD8 + ), and reduced natural killer cell counts, while hepatic and renal function indices remained largely comparable. Conclusions: The winter rebound of MP and CP infections during the epidemic wave of the severe acute respiratory syndrome coronavirus 2 Omicron variant appeared most pronounced among KTRs, especially those with concurrent COVID‐19 infection. The elevated coinfection risk may be explained by combined impairments of adaptive and innate immunity rather than organ dysfunction. These findings underscore the need for heightened surveillance, early diagnostic testing, and tailored preventive strategies for transplant recipients and other high‐risk populations during and after COVID‐19 surges.
- Open Access
- 8 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1698
Hypoxia-inducible factor-1α exacerbates immune injury induced by influenza A virus and Streptococcus pneumoniae coinfection
Influenza A virus (IAV) and Streptococcus pneumoniae (S. pneumoniae) coinfection during influenza pandemics is a significant contributor to mortality, main
- 8 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1698
Open AccessHypoxia-inducible factor-1α exacerbates immune injury induced by influenza A virus and Streptococcus pneumoniae coinfection
Influenza A virus (IAV) and Streptococcus pneumoniae (S. pneumoniae) coinfection during influenza pandemics is a significant contributor to mortality, main
- Open Access
- 8 August 2025
- Published by Springer Nature in Molecular Biomedicine
- Vol. 6 (1) , 55
High sensitivity detection of Hepatitis B virus RNA based on 3D-DNA nanomachine and protein nanopore sensing
Serum Hepatitis B virus (HBV) RNA serves as a non-invasive biomarker for monitoring chronic hepatitis B and guiding treatment decisions. However, current diagnostic tests relying on Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) require centralized facilities and tedious operational steps, and there is currently no standardized HBV RNA detection method. Herein, we describe the rapid amplification-free detection of HBV RNA in clinical serum samples via a nanopore sensing method. Our method involves the design of a DNA nanomachine capable of translation of each target HBV RNA into a large amount of 7-nt single-strand DNA (ssDNA) as signal reporters that produce blockage features when passing through an alpha-hemolysin (α-HL) nanopore, the target can be quantified by identifying the frequency of this blockage occurrence. We demonstrate that this unique nanopore sensing feature not only distinguishes Signal Report (SR) DNA from interfering nucleic acids in clinical serum samples but also ensures a high assay sensitivity with a limit-of-detection (LOD) at 12.5 fM. The clinical potential of this method was validated through testing serum samples from 26 HBV-infected-patients and 7 healthy-participants. When compared with the RT-qPCR method, it showed only one false result, achieving an accuracy rate of 97.0%. Additionally, testing results for 18 cases during the treatment period demonstrated that our method’s conclusions on continued treatment and drug discontinuation were highly consistent with clinical diagnoses, with an accuracy rate of 100%. Therefore, the method developed in this study expands the clinical applications of 3D DNA nanomachine and nanopore sensing technology in clinical detection.
- 8 August 2025
- Published by Springer Nature in Molecular Biomedicine
- Vol. 6 (1) , 55
Open AccessHigh sensitivity detection of Hepatitis B virus RNA based on 3D-DNA nanomachine and protein nanopore sensing
Serum Hepatitis B virus (HBV) RNA serves as a non-invasive biomarker for monitoring chronic hepatitis B and guiding treatment decisions. However, current diagnostic tests relying on Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) require centralized facilities and tedious operational steps, and there is currently no standardized HBV RNA detection method. Herein, we describe the rapid amplification-free detection of HBV RNA in clinical serum samples via a nanopore sensing method. Our method involves the design of a DNA nanomachine capable of translation of each target HBV RNA into a large amount of 7-nt single-strand DNA (ssDNA) as signal reporters that produce blockage features when passing through an alpha-hemolysin (α-HL) nanopore, the target can be quantified by identifying the frequency of this blockage occurrence. We demonstrate that this unique nanopore sensing feature not only distinguishes Signal Report (SR) DNA from interfering nucleic acids in clinical serum samples but also ensures a high assay sensitivity with a limit-of-detection (LOD) at 12.5 fM. The clinical potential of this method was validated through testing serum samples from 26 HBV-infected-patients and 7 healthy-participants. When compared with the RT-qPCR method, it showed only one false result, achieving an accuracy rate of 97.0%. Additionally, testing results for 18 cases during the treatment period demonstrated that our method’s conclusions on continued treatment and drug discontinuation were highly consistent with clinical diagnoses, with an accuracy rate of 100%. Therefore, the method developed in this study expands the clinical applications of 3D DNA nanomachine and nanopore sensing technology in clinical detection.
- 15 May 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 286, 117579
Ultrasensitive clinical identification of hepatitis B surface antigen (HBsAg) by CRISPR-assisted nanopore sensing
- 15 May 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 286, 117579
Ultrasensitive clinical identification of hepatitis B surface antigen (HBsAg) by CRISPR-assisted nanopore sensing
- Open Access
- 1 April 2025
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 18, 1913-1921
Analysis of Manifestations and Associated Factors of HIV-1 Associated Thrombocytopenia in a General Teaching Hospital in Western China
Background: Thrombocytopenia frequently occurs with HIV-1 infection and plays a vital role in the deterioration of the Blood-Brain Barrier (BBB) and the development of neuroinflammation. This study aims to assess the prevalence and risk factors for HIV-1 associated thrombocytopenia (HAT) and summarize the characteristics of HAT-related neuroinflammation. Methods: A retrospective study of HAT patients was conducted in a general teaching hospital from January 2017 to December 2021. Clinical and laboratory data from HIS and LIS were analyzed to determine the prevalence and risk factors for HAT and manifestations of HAT with neuroinflammation. Results: The prevalence of HAT was 11.06%, with a majority of male patients (76.92%), individuals aged 50 and older (55.21%), and 63.80% experiencing mild thrombocytopenia. Significant differences were observed in CD4+ T cell count, platelet crit (PCT), and the proportion of large platelets (P-LCR) between the HAT and control groups (P< 0.001, P< 0.001, P=0.002). A CD4+ T cell count < 200 cells/μL (P=0.001) was identified as a significant risk factor for HAT, while advanced age and high viral load were closely associated with HAT occurrence. HAT Patients with neuroinflammation were predominantly male (X2=10.066, P=0.007), had higher viral loads (X2=12.297, P=0.006), advanced age (X2=11.721, P=0.02), neuropsychiatric symptoms, and elevated levels of inflammatory factors such as IL-6 and proteins in cerebrospinal fluid (CSF). Conclusion: In HIV-1 infection, the activation of monocytes, macrophages, and microglia leads to thrombocytopenia and neuroinflammation, highlighting the importance of recognizing HAT and HAT with neuroinflammation. Advanced age, lower CD4+ T cell count, and high viral load are closely linked to their occurrence.
- 1 April 2025
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 18, 1913-1921
Open AccessAnalysis of Manifestations and Associated Factors of HIV-1 Associated Thrombocytopenia in a General Teaching Hospital in Western China
Background: Thrombocytopenia frequently occurs with HIV-1 infection and plays a vital role in the deterioration of the Blood-Brain Barrier (BBB) and the development of neuroinflammation. This study aims to assess the prevalence and risk factors for HIV-1 associated thrombocytopenia (HAT) and summarize the characteristics of HAT-related neuroinflammation. Methods: A retrospective study of HAT patients was conducted in a general teaching hospital from January 2017 to December 2021. Clinical and laboratory data from HIS and LIS were analyzed to determine the prevalence and risk factors for HAT and manifestations of HAT with neuroinflammation. Results: The prevalence of HAT was 11.06%, with a majority of male patients (76.92%), individuals aged 50 and older (55.21%), and 63.80% experiencing mild thrombocytopenia. Significant differences were observed in CD4+ T cell count, platelet crit (PCT), and the proportion of large platelets (P-LCR) between the HAT and control groups (P< 0.001, P< 0.001, P=0.002). A CD4+ T cell count < 200 cells/μL (P=0.001) was identified as a significant risk factor for HAT, while advanced age and high viral load were closely associated with HAT occurrence. HAT Patients with neuroinflammation were predominantly male (X2=10.066, P=0.007), had higher viral loads (X2=12.297, P=0.006), advanced age (X2=11.721, P=0.02), neuropsychiatric symptoms, and elevated levels of inflammatory factors such as IL-6 and proteins in cerebrospinal fluid (CSF). Conclusion: In HIV-1 infection, the activation of monocytes, macrophages, and microglia leads to thrombocytopenia and neuroinflammation, highlighting the importance of recognizing HAT and HAT with neuroinflammation. Advanced age, lower CD4+ T cell count, and high viral load are closely linked to their occurrence.
- Open Access
- 9 October 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1468521
Handwashing sinks as reservoirs of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a prospective multicenter study
Introduction: The extent to which sinks are contaminated by carbapenem-resistant Acinetobacter baumannii (CRAB) in intensive care units (ICUs) and the association between these contaminated sinks and hospital-acquired CRAB infections during the non-cluster period remains largely unknown. Here, we performed a prospective multicenter study in 16 ICUs at 11 tertiary hospitals in Chengdu, China.Methods: We sampled sinks, collected CRAB clinical isolates, and conducted whole-genome sequencing and analysis.Results: A total of 789 swabs were collected from 158 sinks, and 16 CRAB isolates were recovered from 16 sinks, resulting in a contamination rate of 10.16%. Twenty-seven clinical isolates were collected during the study period. The majority (97.67%, 42/43) of the CRAB isolates belonged to ST2, and 36 (83.72%) of them had both blaOXA-23 and blaOXA-66. The 43 strains belonged to 12 clones. One certain clone caused multiple contaminations of seven sinks in one GICU. Two clones of ST2 blaOXA-23 and blaOXA-66-carrying sink strains were likely the sources of the two clusters in the two GICUs, respectively. Five ST2 blaOXA-23-carrying isolates were found to be common clones but were recovered from two hospitals.Conclusion: The contamination rate of CRAB in handwashing sinks is high in some local ICUs, and the contaminated sinks can serve as environmental reservoirs for CRAB clusters.
- 9 October 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1468521
Open AccessHandwashing sinks as reservoirs of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a prospective multicenter study
Introduction: The extent to which sinks are contaminated by carbapenem-resistant Acinetobacter baumannii (CRAB) in intensive care units (ICUs) and the association between these contaminated sinks and hospital-acquired CRAB infections during the non-cluster period remains largely unknown. Here, we performed a prospective multicenter study in 16 ICUs at 11 tertiary hospitals in Chengdu, China.Methods: We sampled sinks, collected CRAB clinical isolates, and conducted whole-genome sequencing and analysis.Results: A total of 789 swabs were collected from 158 sinks, and 16 CRAB isolates were recovered from 16 sinks, resulting in a contamination rate of 10.16%. Twenty-seven clinical isolates were collected during the study period. The majority (97.67%, 42/43) of the CRAB isolates belonged to ST2, and 36 (83.72%) of them had both blaOXA-23 and blaOXA-66. The 43 strains belonged to 12 clones. One certain clone caused multiple contaminations of seven sinks in one GICU. Two clones of ST2 blaOXA-23 and blaOXA-66-carrying sink strains were likely the sources of the two clusters in the two GICUs, respectively. Five ST2 blaOXA-23-carrying isolates were found to be common clones but were recovered from two hospitals.Conclusion: The contamination rate of CRAB in handwashing sinks is high in some local ICUs, and the contaminated sinks can serve as environmental reservoirs for CRAB clusters.
- Open Access
- 4 September 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 565, 119949
Clinical performance evaluation of an HIV Duo assay: From HIV screening to acute and non-acute HIV infection detection
- 4 September 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 565, 119949
Open AccessClinical performance evaluation of an HIV Duo assay: From HIV screening to acute and non-acute HIV infection detection